A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
CONCLUSIONS: This clinically focused, comprehensive, population-based medication management approach affected real-time change in health services, practice, and outcomes evidenced by widespread and rapid DAA uptake, improved HCV RNA monitoring, attention to adherence, and more appropriate management of DAA-related anemia. Timely outcome sharing provided decision makers and clinicians evidence to support current HCV practices.
PMID: 24856591 [PubMed - in process]
Source: Journal of Managed Care Pharmacy - Category: Drugs & Pharmacology Tags: J Manag Care Pharm Source Type: research
More News: Anemia | Drugs & Pharmacology | Education | Health Management | Hematology | Hepatitis | Hepatitis C | Incivek | Laboratory Medicine | Managed Care | Training | Universities & Medical Training | Virology